UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of March 2017
Commission File Number: 001-36073
ENZYMOTEC LTD.
(Translation of registrant’s name into English)
Sagi 2000 Industrial Area
P.O. Box 6
Migdal Ha’Emeq 2310001, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
CONTENT
On March 10, 2017, Enzymotec Ltd. (“Enzymotec” or the “Company”) issued a press release serving as the notice of the upcoming extraordinary general meeting of shareholders of Enzymotec (the “Meeting”), which will take place on Tuesday, April 25, 2017 at the Company’s offices at Sagi 2000 Industrial Area, Migdal Ha’Emeq 2310001, Israel. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | ENZYMOTEC LTD. | |
| Date: March 10, 2017 | By: | /s/ Oren Bryan | |
| | Name: | Oren Bryan | |
| | Title: | Chief Financial Officer | |
EXHIBIT INDEX
The following exhibit is furnished as part of this Form 6-K:
Exhibit | Description |
| | |
| 99.1 | Press release dated March 10, 2017 entitled “Enzymotec Ltd. Calls an Extraordinary General Meeting of Shareholders”. |
